Artificial Urethra Market, Global Outlook and Forecast 2023-2028

Report ID: 1632630 | Published Date: Jan 2025 | No. of Page: 76 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story

Artificial Urethra is mainly designed as an implanted device to treat moderate to severe stress urinary incontinence, most commonly in men.
This report contains market size and forecasts of Artificial Urethra in global, including the following market information:
Global Artificial Urethra Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Artificial Urethra Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Artificial Urethra companies in 2021 (%)
The global Artificial Urethra market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Silicone Elastomers Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Artificial Urethra include Boston Scientific Corporation, ZEPHYR Surgical Implants, RBM-Med, Silimed and GT Urologica, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Artificial Urethra manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Artificial Urethra Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Artificial Urethra Market Segment Percentages, by Type, 2021 (%)
Silicone Elastomers
Others
Global Artificial Urethra Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Artificial Urethra Market Segment Percentages, by Application, 2021 (%)
Men
Women
Global Artificial Urethra Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Artificial Urethra Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Artificial Urethra revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Artificial Urethra revenues share in global market, 2021 (%)
Key companies Artificial Urethra sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Artificial Urethra sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boston Scientific Corporation
ZEPHYR Surgical Implants
RBM-Med
Silimed
GT Urologica

Frequently Asked Questions
Artificial Urethra Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Artificial Urethra Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Artificial Urethra Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Triazolam Market

Triazolam is a central nervous system (CNS) depressant tranquilizer in the triazolobenzodiazepine ... Read More

Butalbital Market

Butalbital is a barbiturate with an intermediate duration of action. Butalbital is often combined ... Read More